NEOSTIGMINE METHYLSULFATE (Amphastar Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the NEOSTIGMINE METHYLSULFATE drug offered from Amphastar Pharmaceuticals, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amphastar Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | neostigmine methylsulfate |
| SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-25 |
| END MARKETING DATE: | 0000-00-00 |
NEOSTIGMINE METHYLSULFATE HUMAN PRESCRIPTION DRUG Details:
| Item Description | NEOSTIGMINE METHYLSULFATE from Amphastar Pharmaceuticals, Inc. |
| LABELER NAME: | Amphastar Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2017-09-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0548-9601_e4f0003a-c0f1-4784-8dfd-2d9a849ade9f |
| PRODUCT NDC: | 0548-9601 |
| APPLICATION NUMBER: | ANDA209933 |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers:
